Aytu BioPharma Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement CEVA Q1 2026 Earnings EPS Surprises by 122 Amid Strong Licensing Momentum YHGJ Q4 2023 Earnings Positive EPS Lifts Stock Despite Sparse Data STRW Q1 2026 Earnings Earnings Beat Estimates Despite Modest Stock Decline NovaBridge Biosciences NBP Q4 2025 Earnings Staggering EPS Miss as PreRevenue Biotech Faces Development Headwinds CNTN Q4 2023 Earnings EPS Surprises Positively Despite Revenue Absence Stock Declines 65